Poster (Scientific congresses and symposiums)
Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED SCLC).
Bosquee, Léon
20102010 ASCO - Annual Meeting
 

Files


Full Text
Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (.pdf
Publisher postprint (1.16 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Cardiovascular & respiratory systems
Author, co-author :
Bosquee, Léon ;  Université de Liège - ULiège > Pneumologie-Allergologie
Language :
English
Title :
Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED SCLC).
Publication date :
2010
Event name :
2010 ASCO - Annual Meeting
Event place :
Chicago, United States
Event date :
du02 juin 2010 au 10 juin 2010
Audience :
International
Available on ORBi :
since 27 January 2011

Statistics


Number of views
43 (5 by ULiège)
Number of downloads
109 (4 by ULiège)

Bibliography


Similar publications



Contact ORBi